![Matthias Kromayer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthias Kromayer
Directeur Général chez
Tavia Consulting GmbH
Profil
Matthias Kromayer currently works at BIOCRATES Life Sciences AG, as Deputy Chairman-Supervisory Board, AMSilk GmbH, as Vice Chairman-Supervisory Board, Immatics US, Inc., as Director, Tavia Consulting GmbH, as Managing Director, MIG Verwaltungs AG, as Managing Partner from 2010, Ci3 Management UG, as Member, Minaris Regenerative Medicine GmbH, as Member-Supervisory Board, and iOmx Therapeutics AG, as Member-Supervisory Board from 2022.
Dr. Kromayer also formerly worked at ViroLogik GmbH, as Chief Executive Officer, cerbomed GmbH, as Chairman, Nexigen GmbH, as Chairman-Advisory Board & Director, Immatics Biotechnologies GmbH, as Member-Supervisory Board in 2013, and BRAIN Biotech AG, as Member-Supervisory Board from 2011 to 2017.
Dr. Kromayer received his doctorate degree from Ludwig-Maximilians-Universität München.
Postes actifs de Matthias Kromayer
| Sociétés | Poste | Début |
|---|---|---|
MIG Verwaltungs AG
 MIG Verwaltungs AG Investment ManagersFinance MIG Capital seeks investment opportunities in companies located in Europe. The firm focuses on deep tech and life science sectors. It provides financing for early stage capital requirements with an investment size ranging from EURO 1-10 million. | Private Equity Investor | 09/02/2010 |
AMSilk GmbH
 AMSilk GmbH TextilesProcess Industries Produces biotech materials | Directeur/Membre du Conseil | - |
Tavia Consulting GmbH | Directeur Général | - |
BIOCRATES Life Sciences AG
 BIOCRATES Life Sciences AG Medical SpecialtiesHealth Technology Operates as a mass spectrometry-based quantitative metabolite analysis | Directeur/Membre du Conseil | - |
Ci3 Management UG | Corporate Officer/Principal | - |
Immatics US, Inc.
 Immatics US, Inc. BiotechnologyHealth Technology Develops adoptive cell therapies for treatment of cancer | Directeur/Membre du Conseil | - |
Minaris Regenerative Medicine GmbH
 Minaris Regenerative Medicine GmbH BiotechnologyHealth Technology Develops cell-based and gene therapy products | Directeur/Membre du Conseil | - |
iOmx Therapeutics AG
 iOmx Therapeutics AG BiotechnologyHealth Technology Develops immunotherapy treatments for cancer patients | Directeur/Membre du Conseil | 20/07/2022 |
Anciens postes connus de Matthias Kromayer
| Sociétés | Poste | Fin |
|---|---|---|
| BRAIN BIOTECH AG | Directeur/Membre du Conseil | 09/03/2017 |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | - |
Formation de Matthias Kromayer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
34
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH BiotechnologyHealth Technology Operates as a bio technology company that develops and delivers T cell redirecting immunotherapies for treatment of cancer | Health Technology |
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MIG Verwaltungs AG
MIG Verwaltungs AG Investment ManagersFinance MIG Capital seeks investment opportunities in companies located in Europe. The firm focuses on deep tech and life science sectors. It provides financing for early stage capital requirements with an investment size ranging from EURO 1-10 million. | Finance |
BRAIN Biotech AG
 BRAIN Biotech AG BiotechnologyHealth Technology Discovers and develops bioactive natural compounds and proprietary enzymes | Health Technology |
ViroLogik GmbH
 ViroLogik GmbH Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of viral diseases | Health Technology |
cerbomed GmbH
 cerbomed GmbH Medical SpecialtiesHealth Technology Manufactures and supplies medical devices for treating epilepsy | Health Technology |
BIOCRATES Life Sciences AG
BIOCRATES Life Sciences AG Medical SpecialtiesHealth Technology Operates as a mass spectrometry-based quantitative metabolite analysis | Health Technology |
AMSilk GmbH
AMSilk GmbH TextilesProcess Industries Produces biotech materials | Process Industries |
Nexigen GmbH
 Nexigen GmbH Pharmaceuticals: MajorHealth Technology Identifies and develops peptide based therapeutics for cancer | Health Technology |
Ci3 Management UG | |
Immatics US, Inc.
Immatics US, Inc. BiotechnologyHealth Technology Develops adoptive cell therapies for treatment of cancer | Health Technology |
Minaris Regenerative Medicine GmbH
Minaris Regenerative Medicine GmbH BiotechnologyHealth Technology Develops cell-based and gene therapy products | Health Technology |
Tavia Consulting GmbH | |
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology Develops immunotherapy treatments for cancer patients | Health Technology |
Choisissez Zonebourse 
